Novel Peptide Hydrogels Generating Chemical Exchange Saturation Transfer MRI Contrast And Uses Thereof Read more about Novel Peptide Hydrogels Generating Chemical Exchange Saturation Transfer MRI Contrast And Uses Thereof Patent Cooperation TreatyPCT/US2014/035651Filed on 2014-04-28
Novel Indenoisoquinoline Derivatives As Anti-proliferative Agents In Cancer Treatment Read more about Novel Indenoisoquinoline Derivatives As Anti-proliferative Agents In Cancer Treatment US Patent 9,217,010Filed on 2014-07-24
Zirconium-89 Oxine Complex As A Cell Labeling Agent For Positron Emission Tomography Read more about Zirconium-89 Oxine Complex As A Cell Labeling Agent For Positron Emission Tomography Patent Cooperation TreatyPCT/US15/023897Filed on 2015-04-01
METHODS FOR PRODUCING AUTOLOGOUS T CELLS USEFUL TO TREAT B CELL MALIGNANCIES AND OTHER CANCERS AND COMPOSITIONS THEREOF Read more about METHODS FOR PRODUCING AUTOLOGOUS T CELLS USEFUL TO TREAT B CELL MALIGNANCIES AND OTHER CANCERS AND COMPOSITIONS THEREOF US Application 14/614,400Filed on 2015-02-04
METHODS FOR PRODUCING AUTOLOGOUS T CELLS USEFUL TO TREAT B CELL MALIGNANCIES AND OTHER CANCERS AND COMPOSITIONS THEREOF Read more about METHODS FOR PRODUCING AUTOLOGOUS T CELLS USEFUL TO TREAT B CELL MALIGNANCIES AND OTHER CANCERS AND COMPOSITIONS THEREOF Patent Cooperation TreatyPCT/US2015/014520Filed on 2015-02-04
Brachyury Protein, Non-Poxvirus Non-Yeast Vectors Encoding Brachyury Protein, and Their Use Read more about Brachyury Protein, Non-Poxvirus Non-Yeast Vectors Encoding Brachyury Protein, and Their Use US Application 14/428,308Filed on 2015-03-13
BRACHYURY PROTEIN, NON-POXVIRUS NON-YEAST VECTORS ENCODING BRACHYURY PROTEIN, AND THEIR USE Read more about BRACHYURY PROTEIN, NON-POXVIRUS NON-YEAST VECTORS ENCODING BRACHYURY PROTEIN, AND THEIR USE European Patent13773456.2Filed on 2013-09-13
BRACHYURY POLYPEPTIDES AND METHODS FOR USE Read more about BRACHYURY POLYPEPTIDES AND METHODS FOR USE European Patent15162282.6Filed on 2008-02-27
Use of GTF21 Mutations in the Prognosis of Thymic Cancers Read more about Use of GTF21 Mutations in the Prognosis of Thymic Cancers US Patent 9,493,842Filed on 2015-04-02
Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer Read more about Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer Hong Kong18102573.1Filed on 2018-02-22